AU1413301A - Diabetic remedy containing dipiperazine derivative - Google Patents

Diabetic remedy containing dipiperazine derivative

Info

Publication number
AU1413301A
AU1413301A AU14133/01A AU1413301A AU1413301A AU 1413301 A AU1413301 A AU 1413301A AU 14133/01 A AU14133/01 A AU 14133/01A AU 1413301 A AU1413301 A AU 1413301A AU 1413301 A AU1413301 A AU 1413301A
Authority
AU
Australia
Prior art keywords
dipiperazine
derivative
remedy containing
diabetic
diabetic remedy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU14133/01A
Inventor
Kiyotaka Iwai
Katsunori Maruta
Ryu Nagata
Kantaro Ushiroda
Hiroshi Yamaguchi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sumitomo Pharmaceuticals Co Ltd
Original Assignee
Sumitomo Pharmaceuticals Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sumitomo Pharmaceuticals Co Ltd filed Critical Sumitomo Pharmaceuticals Co Ltd
Publication of AU1413301A publication Critical patent/AU1413301A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
    • C07D295/182—Radicals derived from carboxylic acids
    • C07D295/185—Radicals derived from carboxylic acids from aliphatic carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
    • C07D295/182—Radicals derived from carboxylic acids
    • C07D295/192—Radicals derived from carboxylic acids from aromatic carboxylic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/20—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof
    • C07D295/215—Radicals derived from nitrogen analogues of carbonic acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/22—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with hetero atoms directly attached to ring nitrogen atoms
    • C07D295/26—Sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/02—Systems containing only non-condensed rings with a three-membered ring
AU14133/01A 1999-11-17 2000-11-15 Diabetic remedy containing dipiperazine derivative Abandoned AU1413301A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP11/326751 1999-11-17
JP32675199 1999-11-17
PCT/JP2000/008065 WO2001036386A1 (en) 1999-11-17 2000-11-15 Diabetic remedy containing dipiperazine derivative

Publications (1)

Publication Number Publication Date
AU1413301A true AU1413301A (en) 2001-05-30

Family

ID=18191288

Family Applications (1)

Application Number Title Priority Date Filing Date
AU14133/01A Abandoned AU1413301A (en) 1999-11-17 2000-11-15 Diabetic remedy containing dipiperazine derivative

Country Status (2)

Country Link
AU (1) AU1413301A (en)
WO (1) WO2001036386A1 (en)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPWO2002043760A1 (en) * 2000-12-01 2004-04-02 住友製薬株式会社 Sugar metabolism activator
WO2003007990A1 (en) * 2001-07-18 2003-01-30 Sumitomo Pharmaceuticals Company, Limited Myosin agonist
PE20030705A1 (en) * 2001-10-17 2003-08-21 Schering Corp 17BETA-HYDROXIESTEROID DEHYDROGENASE TYPE 3 INHIBITORS FOR THE TREATMENT OF ANDROGEN-DEPENDENT DISEASES
US7253168B2 (en) 2004-04-07 2007-08-07 Neurogen Corporation Substituted 1-benzyl-4-substituted piperazine analogues
CA2589565A1 (en) * 2004-06-24 2006-01-05 Incyte Corporation Amido compounds and their use as pharmaceuticals
US7361672B2 (en) * 2004-12-23 2008-04-22 Hoffmann-La Roche Inc. Heteroarylacetamide inhibitors of factor Xa
UY29321A1 (en) * 2004-12-30 2006-03-31 Janssen Pharmaceutica Nv PIPERAZINILUREAS AND PIPERIDINILUREAS AS AMID HYDROLASSES MODULATORS OF FATTY ACIDS
JP5268264B2 (en) * 2007-02-07 2013-08-21 住友精化株式会社 Method for producing alkanedisulfonyl halide
JP5513054B2 (en) * 2009-09-30 2014-06-04 富士フイルム株式会社 Cellulose acylate film, retardation plate, polarizing plate, and liquid crystal display device
UA108233C2 (en) 2010-05-03 2015-04-10 Fatty acid amide hydrolysis activity modulators
KR101260130B1 (en) 2011-01-04 2013-05-02 중앙대학교 산학협력단 Novel specific TRPV4 agonist and medical use thereof
US10092574B2 (en) 2012-09-26 2018-10-09 Valorisation-Recherche, Limited Partnership Inhibitors of polynucleotide repeat-associated RNA foci and uses thereof
US9063420B2 (en) 2013-07-16 2015-06-23 Rohm And Haas Electronic Materials Llc Photoresist composition, coated substrate, and method of forming electronic device
US9410016B2 (en) 2013-07-16 2016-08-09 Dow Global Technologies Llc Aromatic polyacetals and articles comprising them
US8962779B2 (en) 2013-07-16 2015-02-24 Dow Global Technologies Llc Method of forming polyaryl polymers
US8933239B1 (en) 2013-07-16 2015-01-13 Dow Global Technologies Llc Bis(aryl)acetal compounds
CN107021940A (en) * 2017-05-03 2017-08-08 天津国际生物医药联合研究院 A kind of BISPIP class compound and its application

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2159229C2 (en) * 1994-09-23 2000-11-20 Эксис Фармасьютикалз, Инк. Cycloalkylene or heterocycloalkylene derivatives, pharmaceutical composition, aerosol device, and medical treatment method
EP0934293A1 (en) * 1996-07-30 1999-08-11 Arris Pharmaceutical Corporation Novel compounds and compositions for treating diseases associated with tryptase activity
AU5625499A (en) * 1998-09-04 2000-03-27 Altana Pharma Ag Novel pyranoses

Also Published As

Publication number Publication date
WO2001036386A1 (en) 2001-05-25

Similar Documents

Publication Publication Date Title
AU2955200A (en) Cannula
AU5760900A (en) Multiple agent diabetes therapy
AU6314900A (en) Biarylurea derivatives
AU6714700A (en) Cyclopropylindole derivatives
AU5413600A (en) Compounds
AU1071301A (en) Pharmaceutical compounds
AU2730600A (en) Medical adhesives
AU2919001A (en) Syringe
AU1413301A (en) Diabetic remedy containing dipiperazine derivative
AU2002214006A1 (en) Drugs for diabetes
AU5429000A (en) Novel bicyclonucleoside derivatives
AU3670000A (en) Novel thiazolobenzimidazole derivatives
AU7952800A (en) 2-alkoxybenzene derivatives
AU6032100A (en) New compounds
AU1746401A (en) Compounds
AU7453900A (en) 4-oxybenzopyran derivative
AUPQ262599A0 (en) Gene expression
AU1645700A (en) Oenothein medicaments
AU7593800A (en) Small library works-in-a-drawer
AU5722900A (en) Pharmaceutical compounds
AU4188500A (en) Protein c derivatives
AU5887400A (en) Derivative compounds
AU1751801A (en) Protein c derivatives
AU5016200A (en) Diabetes gene
AU1857701A (en) Benzoxa- and benzthiazoles

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase